Clinical Trial Update: Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operative Pancreatic Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing gemcitabine, S-1, and gemcitabine plus nab-paclitaxel as adjuvant chemotherapy for post-operative pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Cancer of Pancreas | Phase 2 | Status: UNKNOWN